Canada pledges C$ 125 million to IFFIm
Canada pledges C$ 125 million to IFFIm
17 March 2023
L-R: Ken Lay, IFFIm Board Chair, Marie-Ange Saraka-Yao, Managing Director, Resource Mobilisation, Private Sector Partnerships and Innovative Finance, Gavi, and Joshua Tabah, Director General, Global Health and Nutrition, Global Affairs Canada.
Canada expands its commitment to childhood immunisation as 11th donor to IFFIm
- Canada expands its commitment to childhood immunisation as 11th donor to IFFIm
- C$ 125 million grant brings IFFIm’s donor support to nearly US$ 10 billion committed through 2037
- Seth Berkley, Gavi CEO: “Canada’s pledge will support Gavi’s work getting routine immunisation back on track in 2023 and renewing our conviction that no child is too hard to reach.”
London, 17 March 2023 – Canada has become the 11th sovereign donor to support the International Finance Facility for Immunisation (IFFIm) with a long-term pledge of C$ 125 million paid over eight years. The pledge is part of Canada’s commitment of C$ 600 million for Gavi, the Vaccine Alliance's 2021 to 2025 strategic period, and extends Canada's support for Gavi's mission, including reaching 14 million zero dose children who have never been vaccinated and strengthening the routine immunisation programmes that lagged in low-income countries during the pandemic. Canada joins current IFFIm donors Australia, Brazil, France, Italy, the Netherlands, Norway, Spain, Sweden, South Africa and the United Kingdom.
Canada’s donor agreement, signed on 28 February 2023, will accelerate funding for immunisation programmes in Gavi-eligible countries. With the new C$ 125 million grant, IFFIm’s donor support has reached nearly US$ 10 billion committed over a 32-year period through 2037.
To date, IFFIm has leveraged long-term pledges to raise close to US$ 9 billion on capital markets. IFFIm funding supports Gavi’s immunisation, health system strengthening, and vaccine development programmes. These have contributed materially to the health of people in the world’s poorest countries, cutting childhood mortality in half.
“Canada is pleased to join IFFIm, especially at a critical moment for reclaiming gains in routine immunisation after years of pandemic-related disruption. Canada’s support will enable increased, immediate efforts by Gavi to strengthen immunisation systems and reach zero-dose children, while also reinforcing preparedness to respond to future challenges,” said the Honourable Harjit S. Sajjan, Minister of International Development and Minister responsible for the Pacific Economic Development Agency of Canada.
“We are very grateful for Canada’s longstanding partnership with Gavi and additional innovative grant funding through IFFIm,” said Gavi CEO Dr Seth Berkley. “Canada’s pledge will support Gavi’s work getting routine immunisation back on track in 2023 and renewing our conviction that no child is too hard to reach, including zero-dose children who have never received a single vaccine and women and girls in remote areas.”
“Canada’s commitment as IFFIm’s 11th sovereign donor is a milestone in our history,” said Ken Lay, Chair of the IFFIm Board of Directors. “IFFIm's strong donor base makes it possible to access capital markets cost-effectively and at scale to broaden coverage for both routine childhood vaccination and emergency response.”
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.
Reflections on IFFIm: an interview with Rachel Turner
14 November 2024